Education
About Us
Working with TipRanks
Follow Us
Theralink Technologies (THER)
:THER
THER Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EST
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume10.00
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$998.28K
Total Debt (Recent Filing)$19.76M
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.15
Price to Sales (P/S)9.12
P/FCF Ratio-0.93
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
THER FAQ
What was Theralink Technologies’s price range in the past 12 months?
Currently, no data Available
What is Theralink Technologies’s market cap?
Currently, no data Available
When is Theralink Technologies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Theralink Technologies’s earnings last quarter?
Currently, no data Available
Is Theralink Technologies overvalued?
According to Wall Street analysts Theralink Technologies’s price is currently Overvalued.
Does Theralink Technologies pay dividends?
Theralink Technologies does not currently pay dividends.
What is Theralink Technologies’s EPS estimate?
Theralink Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Theralink Technologies have?
Currently, no data Available
What happened to Theralink Technologies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Theralink Technologies?
Currently, no hedge funds are holding shares in THER
Company Description
Theralink Technologies
Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products. The company through its patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to FDA-approved and investigational drug treatments. The company's data-generating assays provide actionable information for physicians, patients, and biopharmaceutical companies in the area of oncology. Theralink Technologies, Inc. was formerly known as OncBioMune Pharmaceuticals, Inc. and changed its name to Theralink Technologies, Inc. in September 2020. The company is headquartered in Golden, Colorado.
Biodexa Pharmaceuticals
―
Salarius Pharmaceuticals
―
Processa Pharmaceuticals
―
GRI Bio
―
Onconetix
―